Generation

Momentum

Time

<h3 id="key-highlights">Key Highlights</h3>
<ul>
 <li>Palantir shares dropped to a 52-week bottom of $107.27 during Thursday’s session, declining 5.5% and registering a 39% year-to-date loss</li>
 <li>The data analytics company has shed 31% of its value this month, potentially marking its steepest monthly decline since February 2021</li>
 <li>ARK Invest, managed by Cathie Wood, acquired 30,528 shares of PLTR valued at approximately $3.3 million based on Thursday’s closing price</li>
 <li>ARK’s portfolio moves also included a $18.9M Cerebras purchase and approximately $16.7M in Alibaba sales</li>
 <li>Analyst community maintains an average Overweight stance with a $189.87 target price, suggesting 77% potential upside</li>
</ul>
Shares of Palantir (PLTR) climbed 0.8% to $108.12 during Friday’s premarket trading, attempting to recover from Thursday’s close at $107.27 — representing a new 52-week bottom and marking the seventh consecutive session of losses.
<a href="https://knockoutstocks.com/stock/PLTR" rel="noopener noreferrer nofollow"> <img src="https://knockoutstocks.com/api/stocks/PLTR/embed" alt="PLTR Stock Card"> Palantir Technologies Inc., PLTR </a>
The 5.5% decline on Thursday compounded an already difficult period for shareholders of the data analytics firm. PLTR has surrendered 20% of its value in the past two weeks and experienced a 31% monthly contraction.
Should the stock finish Friday’s session in negative territory, it would represent an eighth straight day of declines — a streak that would position it for its most severe monthly percentage retreat since experiencing a 32% slide in February 2021, according to Dow Jones Market Data.
<a href="https://coincentral.com/palantir-pltr-stock-at-12-month-low-time-to-buy-or-more-pain-ahead/" rel="noopener noreferrer nofollow">PLTR</a> has tumbled 39% since the start of 2026, representing a dramatic pivot following three consecutive years of substantial appreciation. By comparison, the S&amp;P 500 has advanced 7.5% while the Nasdaq Composite has gained 9% during the identical timeframe.
The shares currently trade 48% beneath their all-time closing peak of $207.18, achieved on November 3, 2025.
<h3 id="critical-support-levels-give-way">Critical Support Levels Give Way</h3>
Earlier this week, PLTR breached the $127 threshold — a support zone that had remained intact since February. The stock now trades 15% lower than that benchmark.
Thursday delivered another technical breakdown: shares fell through $128, a crucial weekly chart support that had provided stability for the previous 12 months.
The equity also resides considerably below both primary moving averages. The 50-day moving average hovers around $137, while the 200-day moving average stands near $159.
<h3 id="cathie-wood-s-firm-seizes-the-opportunity">Cathie Wood’s Firm Seizes the Opportunity</h3>
As shares reached their lows, ARK Invest made its move. During Thursday’s trading, <a href="https://coincentral.com/cathie-wood-buys-more-coinbase-circle-and-robinhood-stock-as-prices-fall/" rel="noopener noreferrer nofollow">Cathie Wood’s</a> investment firm acquired 30,528 shares of PLTR distributed among the ARK Innovation ETF (ARKK), the ARK Next Generation Internet ETF (ARKW), and the ARK Blockchain &amp; Fintech Innovation ETF (ARKF), representing approximately $3.3 million in total value.
Palantir currently represents 2.4%, 2.3%, and 3.7% of these three respective funds.
ARK’s activity extended beyond Palantir. The firm also accumulated 111,989 shares of Cerebras Systems (CBRS) through ARKK and ARKW, amounting to approximately $18.9 million based on CBRS’s closing price of $168.52.
Regarding dispositions, ARK divested 176,004 shares of Alibaba (BABA) across ARKF, ARKK, and ARKW — a transaction valued at roughly $16.7 million. Alibaba has encountered headwinds following allegations from Anthropic concerning AI model distillation practices.
ARK additionally acquired 9,014 Coinbase (COIN) shares and purchased 891,473 shares of Recursion Pharmaceuticals (RXRX). The firm sold 130,666 Roku (ROKU) shares and disposed of 37,555 Twist Bioscience (TWST) shares.
On the bearish spectrum, Michael Burry has commented on PLTR, highlighting subdued trading volume and identifying the stock’s pattern as indicative of an extended downward trend.
Notwithstanding the selling pressure, the Street’s consensus outlook on PLTR remains relatively optimistic. Among 33 analysts monitored by FactSet, 17 assign it a Buy rating, three recommend Overweight, 11 suggest Hold, and two advise Sell. The consensus price target reaches $189.87 — representing a 77% premium relative to Thursday’s closing price.
Palantir’s Benzinga Edge Momentum score currently resides in the 5th percentile, while its Value score registers in the 2nd percentile.
The post <a href="https://blockonomi.com/ark-invest-scoops-up-palantir-pltr-stock-as-shares-hit-52-week-low-is-it-time-to-follow/" rel="noopener noreferrer nofollow">ARK Invest Scoops Up Palantir (PLTR) Stock as Shares Hit 52-Week Low—Is It Time to Follow?</a> appeared first on <a href="https://blockonomi.com" rel="noopener noreferrer nofollow">Blockonomi</a>.

ARK Invest Scoops Up Palantir (PLTR) Stock as Shares Hit 52-Week Low—Is It Time to Follow?

Table of Contents

Blockonomi

Other articles published on Jun 26, 2026

Join our free newsletter for daily crypto updates!